A new trading day began on Friday, with Pfizer Inc (NYSE: PFE) stock price up 0.68% from the previous day of trading, before settling in for the closing price of $23.6. PFE’s price has ranged from $20.92 to $30.43 over the past 52 weeks.
Over the past five-year period, the drop rate of yearbook sales for the company of the Healthcare sector was -13.27%. Meanwhile, its annual earnings per share averaged -1.29%. With a float of $5.68 billion, this company’s outstanding shares have now reached $5.68 billion.
Pfizer Inc (PFE) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Drug Manufacturers – General Industry. The insider ownership of Pfizer Inc is 0.12%, while institutional ownership is 66.73%. The most recent insider transaction that took place on May 23 ’25, was worth 1,380,632. Before that another transaction happened on May 05 ’25, when Company’s Former Officer proposed sale 55,000 for $23.87, making the entire transaction worth $1,312,736.
Pfizer Inc (PFE) Earnings and Forecasts
In its latest quarterly report, released on 9/30/2024, the company reported earnings of 1.06 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.66 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -1.29% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 0.06% during the next five years compared to -13.27% drop over the previous five years of trading.
Pfizer Inc (NYSE: PFE) Trading Performance Indicators
Here are Pfizer Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 0.85. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.12. Likewise, its price to free cash flow for the trailing twelve months is 10.86.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 1.88, a number that is poised to hit 0.72 in the next quarter and is forecasted to reach 3.15 in one year’s time.
Technical Analysis of Pfizer Inc (PFE)
Compared to the last year’s volume of 45.32 million, its volume of 47.32 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 17.25%.
During the past 100 days, Pfizer Inc’s (PFE) raw stochastic average was set at 43.24%, which indicates a significant increase from 14.06% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.42 in the past 14 days, which was lower than the 0.45 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $24.55, while its 200-day Moving Average is $24.82. Nevertheless, the first resistance level for the watch stands at $23.84 in the near term. At $23.93, the stock is likely to face the second major resistance level. The third major resistance level sits at $24.04. If the price goes on to break the first support level at $23.64, it is likely to go to the next support level at $23.53. Should the price break the second support level, the third support level stands at $23.44.
Pfizer Inc (NYSE: PFE) Key Stats
With a market capitalization of 135.09 billion, the company has a total of 5,685,551K Shares Outstanding. Currently, annual sales are 63,627 M while annual income is 8,031 M. The company’s previous quarter sales were 14,653 M while its latest quarter income was 2,910 M.
